idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Grafik: idw-Logo

idw - Informationsdienst
Wissenschaft

Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instance:
Share on: 
06/08/2022 12:25

Dopamine can influence bone metabolism in arthritis

Anne Rommel Presse- und Öffentlichkeitsarbeit
Leibniz-Institut für Arbeitsforschung an der TU Dortmund

    Rheumatoid arthritis (RA) is the most common inflammatory disease of the joints. Nowadays, there are many therapies that can significantly reduce the symptoms However, bone loss and osteoporosis are still a problem. Building on previous studies, researchers at the Leibniz Research Centre for Working Environment and Human Factors in Dortmund (IfADo) have taken a closer look at the role of the neurotransmitter dopamine in the bone metabolism of RA patients. They conclude that dopamine can be used for new therapeutic approaches to control bone loss in rheumatoid arthritis.

    In a current project, Prof. Dr. Silvia Capellino's group has investigated the importance of the biochemical messenger dopamine for the bone formation process in rheumatoid arthritis. Dopamine is a neurotransmitter of the central nervous system that controls movement, emotions, and cognition. Dopamine receptors, the receiving unit for signals through the neurotransmitter dopamine, were found in bone tissue.

    The presence of dopamine receptors in RA patients suggests that dopamine also plays a role in the physiology of human bone metabolism. Therefore, the researchers hypothesised that the signalling pathway activated by dopamine in inflamed joints also influences bone metabolism in rheumatoid arthritis. From this, they deduced that deciphering these dopamine-regulated signalling pathways in bone metabolism may pave the way for new therapeutic approaches to control bone loss.

    Background: Rheumatoid arthritis

    Rheumatoid arthritis is an autoimmune disease characterised by chronic joint inflammation and subsequent joint destruction that can lead to complete loss of function. Furthermore, rheumatoid arthritis is not only a disease of the joints but can also affect many other organs and cause systemic osteoporosis, for example.

    Current therapies target osteoclasts (bone cells responsible for reducing bone substance) to reduce bone loss. However, more treatment options would be needed to promote bone protection by directly acting on osteoblasts (bone cells responsible for building bone substance).


    Contact for scientific information:

    Prof. Dr. Silvia Capellino
    Head of Group Neuroimmunology
    Phone: +49 231 1084-420
    Email: capellino@ifado.de


    Original publication:

    Schwendich, E.; Salinas Tejedor, L.; Schmitz, G.; Rickert, M.; Steinmeyer, J.; Rehart, S.; Tsiami, S.; Braun, J.; Baraliakos, X.; Reinders, J.; Neumann, E.; Müller-Ladner, U.; Capellino, S. Modulation of Dopamine Receptors on Osteoblasts as a Possible Therapeutic Strategy for Inducing Bone Formation in Arthritis. Cells 2022, 11, 1609. https://doi.org/10.3390/cells11101609


    Images

    Criteria of this press release:
    Journalists
    Biology, Medicine, Nutrition / healthcare / nursing
    transregional, national
    Research results
    English


     

    Help

    Search / advanced search of the idw archives
    Combination of search terms

    You can combine search terms with and, or and/or not, e.g. Philo not logy.

    Brackets

    You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).

    Phrases

    Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.

    Selection criteria

    You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).

    If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).